A new clinical trial suggests that semaglutide — the active ingredient in the widely used drugs Ozempic and Wegovy — may help ...

There is initial evidence that low-dose semaglutide may reduce craving and drinking outcomes in individuals with alcohol-use disorder.

(HealthDay News) — Low-dose semaglutide seems to reduce craving and certain drinking outcomes in alcohol use disorder (AUD), according to a study published online in JAMA Psychiatry. Christian S.

For years, people taking GLP-1 type drugs (e.g., Ozempic, Wegovy) have noticed that the medicines didn’t just help them to ...

Studies show promising results for semaglutide as a potential treatment for alcohol use disorder. Semaglutide, a GLP-1 drug, was initially used for type 2 diabetes treatment and weight loss. While ...

There are early and suggestive data that GLP-1 drugs reduce alcohol cravings. A large cohort of people with alcohol use ...

For many Americans, St. Patrick’s Day is a moment to don green apparel and indulge in drinking a few – or more than a few – ...

Headlines are claiming that researchers have shown that semaglutide causes people with alcohol use disorder to feel fewer cravings and actually drink less booze. If true, this could have massive ...

showed improvements in certain measures of alcohol use disorder during a nine-week trial. The Danish drugmaker is also testing semaglutide - sold as the diabetes drug Ozempic and the obesity drug ...

Among participants in the semaglutide treatment group ... and grams of alcohol consumed among individuals with alcohol use disorder (AUD), according to results of a study published in JAMA ...